PF-06305591 Uses, Dosage, Side Effects and more
Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).
| Attribute | Details |
|---|---|
| Trade Name | PF-06305591 |
| Generic | PF-06305591 |
| Type | |
| Formula | C15H22N4O |
| Weight | Average: 274.368 Monoisotopic: 274.179361344 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
